Edap Tms SA
EDAP2.500USD
+0.160+6.84%
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
93.48M시가총액
손실P/E TTM
자세한 내용은 Edap Tms SA 회사
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
회사 정보
종목 코드 EDAP
회사 이름Edap Tms SA
상장일Aug 01, 1997
CEOMr. Jean-Francois Bachelard
직원 수310
유형Depository Receipt
회계 연도 종료Aug 01
주소4, rue du Dauphine
도시VAULX-EN-VELIN
증권 거래소NASDAQ Global Market Consolidated
국가France
우편 번호69120
전화33472153150
웹사이트https://focalone.com/fr/accueil/
종목 코드 EDAP
상장일Aug 01, 1997
CEOMr. Jean-Francois Bachelard
회사 임원
이름
이름/직위
직위
주식 보유
변동
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
Jeon Jon-hyeon
Jeon Jon-hyeon
General Manager of EDAP TMS Korea
General Manager of EDAP TMS Korea
--
--
Alex Fromm
Alex Fromm
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Mr. Frederic Pech
Mr. Frederic Pech
President of EDAP TMS France SAS
President of EDAP TMS France SAS
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
Jeon Jon-hyeon
Jeon Jon-hyeon
General Manager of EDAP TMS Korea
General Manager of EDAP TMS Korea
--
--
Alex Fromm
Alex Fromm
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbH
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Mr. Frederic Pech
Mr. Frederic Pech
President of EDAP TMS France SAS
President of EDAP TMS France SAS
--
--
수익 분석
통화: EUR마지막 업데이트: Sun, Jul 6
통화: EUR마지막 업데이트: Sun, Jul 6
FY2024
데이터 없음
지역별EUR
이름
수익
비율
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Sep 10
마지막 업데이트: Wed, Sep 10
주주
주주 유형
주주
주주
비율
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Bruce & Company, Inc.
1.48%
Apis Capital Advisors LLC
0.61%
기타
65.98%
주주
주주
비율
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Bruce & Company, Inc.
1.48%
Apis Capital Advisors LLC
0.61%
기타
65.98%
주주 유형
주주
비율
Hedge Fund
24.66%
Research Firm
9.12%
Investment Advisor
3.81%
Investment Advisor/Hedge Fund
0.23%
Bank and Trust
0.01%
기타
62.17%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
84
15.58M
41.67%
-2.25M
2025Q1
89
15.47M
41.38%
-2.38M
2024Q4
92
15.39M
41.47%
-2.59M
2024Q3
91
15.67M
42.24%
-3.03M
2024Q2
88
16.06M
43.28%
-2.91M
2024Q1
94
16.22M
43.72%
-3.26M
2023Q4
91
15.98M
43.08%
-4.16M
2023Q3
94
15.98M
43.28%
-3.85M
2023Q2
97
16.26M
44.04%
-2.56M
2023Q1
99
14.83M
40.17%
-3.58M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Soleus Capital Management, L.P.
7.31M
19.55%
--
--
Mar 31, 2025
Morgan Stanley & Co. International Plc
3.36M
9%
-3.01K
-0.09%
Mar 31, 2025
Rock Springs Capital Management LP
1.27M
3.4%
-321.80K
-20.22%
Mar 31, 2025
Bruce & Company, Inc.
553.65K
1.48%
--
--
Mar 31, 2025
Apis Capital Advisors LLC
524.00K
1.4%
+5.00K
+0.96%
Mar 31, 2025
UBS Financial Services, Inc.
38.46K
0.1%
-6.69K
-14.82%
Mar 31, 2025
Schonfeld Strategic Advisors LLC
166.43K
0.45%
+5.63K
+3.50%
Mar 31, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Mar 31, 2025
Cahill Financial Advisors, Inc.
134.96K
0.36%
--
--
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
